Immatics (IMTX) Equity Income (2021 - 2025)
Immatics (IMTX) reported Equity Income of $79.6 million for Q2 2025, up 310.99% on a YoY basis from $19.4 million in Q2 2024, and up 310.99% sequentially from $19.4 million in Q2 2024.
Immatics (IMTX) Equity Income (2021 - 2025) Analysis & Trends
Immatics (IMTX) has 5 years of Equity Income data on file, last reported at $79.6 million in Q2 2025.
- For the quarter ending Q2 2025, Equity Income rose 310.99% year-over-year to $79.6 million; the trailing twelve-month figure through Jun 2025 stood at $44.6 million (up 638.66% YoY), and the FY2025 full-year result was -$221.9 million, down 1447.51% from the prior year.
- Equity Income advanced to $79.6 million in Q2 2025, from $19.4 million in the prior quarter.
- In the past five years, Equity Income ranged from a high of $96.1 million in Q1 2022 to a low of -$28.8 million in Q3 2023.
- A 5-year average of $9.6 million and a median of -$2.1 million in 2021 frame the typical range for Equity Income.
- Peak annual rise in Equity Income reached 449.38% in 2022, while the deepest fall reached 165.8% in 2022.
- Tracing IMTX's Equity Income over 5 years: stood at -$19.2 million in 2021, then dropped by 22.42% to -$23.5 million in 2022, then declined by 8.94% to -$25.6 million in 2023, then soared by 175.65% to $19.4 million in 2024, then soared by 310.99% to $79.6 million in 2025.
- Business Quant data shows IMTX's Equity Income at $79.6 million in Q2 2025, $19.4 million in Q2 2024, and -$25.6 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 79.63 Mn |
| Jun 30, 2024 | 19.38 Mn |
| Dec 31, 2023 | -25.61 Mn |
| Sep 30, 2023 | -28.84 Mn |
| Jun 30, 2023 | 26.80 Mn |
| Mar 31, 2023 | -21.20 Mn |
| Dec 31, 2022 | -23.51 Mn |
| Sep 30, 2022 | -21.11 Mn |
| Jun 30, 2022 | 14.92 Mn |
| Mar 31, 2022 | 96.14 Mn |
| Dec 31, 2021 | -19.20 Mn |
| Sep 30, 2021 | 32.08 Mn |
| Jun 30, 2021 | 31.95 Mn |
| Mar 31, 2021 | -27.52 Mn |